Spirobooth: Innovation to Mitigate COVID19 Risk in the Lung Function Laboratory
Care Process & Redesign
Technology
Not Applicable
SingHealth
31 December 2022
Develop SpiroBooth to safely conduct spirometry during and beyond COVID-19. SpiroBooth demonstrated success and may serve as a model for global lung function labs.
Year Submitted: 2022
Published Date: 31 December 2022
Tags: Care Process ＆ Redesign, Technology, Productivity, Value Based Care, Risk Management, Job Effectiveness, Operational Management, Safe Care, Build Environment, Space Planning, Facilities Management Improvements, Facilities Engineering, Inventory Space Management
About this Content
Aims
Develop SpiroBooth to safely conduct spirometry during and beyond COVID-19.
Background
COVID-19 limited spirometry due to its aerosol-generating nature, necessitating safer procedures.
Methods
Designed, validated, and installed SpiroBooths to meet clinical and operational needs.
Results
Achieved 37.3% increased capacity and a 41% reduction in turnaround time while improving safety and patient satisfaction.
Conclusion
SpiroBooth demonstrated success and may serve as a model for global lung function labs.
Lessons Learnt
Streamlined processes enhance operational capacity and align with infection control requirements.
Additional Information
Merit Award at Singapore Healthcare Management Congress 2022.
Keywords
Spirometry, Aerosol Generating Procedure, SpiroBooth
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | SingHealth |
Organization(s) Involved | KK Women and Children Hospital |
Platform(s) | Not Applicable |
Healthcare Professional Group(s) | Medical |
Applicable Specialty or Discipline | Respiratory Therapy, Infectious Diseases, Pulmonology, Epidemiology |
Project Lead(s) | Biju Thomas |
Project Member(s) | Yoke Hwee Chan |
Connect with this contributor!
Biju Thomas - singaporehealthcaremanagement@singhealth.com.sg